June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Conjunctival Bacterial Resistance Patterns to Antibiotics for Intravitreal Injection: Effects of Maxitrol and Betadine in Clinical Practice
Author Affiliations & Notes
  • Enoch Kassa
    Ophthalmology, Indiana University School of Medicine, Indianapolis, IN
  • Jonathan Gambrell
    Ophthalmology, Indiana University School of Medicine, Indianapolis, IN
    Ophthalmology, Louisville University, Louisville, KY
  • Yang Sun
    Ophthalmology, Indiana University School of Medicine, Indianapolis, IN
  • Charles Barr
    Ophthalmology, Louisville University, Louisville, KY
  • Footnotes
    Commercial Relationships Enoch Kassa, None; Jonathan Gambrell, None; Yang Sun, American GLX society (R), Indiana university BRG (R), Lowe syndrome society (R), NIH (R), Research to prevent blindness (R), Ziegler Foundation (R); Charles Barr, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 286. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Enoch Kassa, Jonathan Gambrell, Yang Sun, Charles Barr; Conjunctival Bacterial Resistance Patterns to Antibiotics for Intravitreal Injection: Effects of Maxitrol and Betadine in Clinical Practice. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):286.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine if intravitreal injections are conducted in a properly sterilized environment. Endophthalmitis is the most feared complication of intravitreal injections. Conventionally, anti-septics without antibiotics are used to sterilize the conjunctival surface before injections. This study investigates the effect of Maxitrol (neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension) on bacterial isolates when used in addition to betadine 5%.

Methods: This is a randomized prospective study from 2011-2012 at the University of Louisville School of Medicine Department of Ophthalmology. Eighty-six patients requiring intravitreal injections were enrolled in the study, with 110 eyes randomized into 55 control sample and 55 treatment sample. A swab culture was obtained on all eyes before any anti-bacterial or anti-septic application. A second swab culture was obtained post application of the sterilizing agents and/or antibiotic. Sensitivities were obtained and the cultures from each group were counted and compared. Statistical analysis was performed using SASS.

Results: Conjunctival swab cultures were initially obtained from 110 eyes. 50 swabs from untreated eyes grew bacteria (n=110, 45%). 55 eyes were then treated with betadine 5% and the other 55 eyes were treated with a combination of Maxitrol and Betadine 5%. 20 swabs from eyes treated without Maxitrol grew bacteria while 8 swabs treated with Maxitrol grew bacteria (n=110, p-value=0.0084). The most common bacteria isolated was coagulase negative staphylococcus (CNS) (63 %). 15 (75%) swabs from eyes treated without Maxitrol grew CNS while 4 (50%) swabs from Maxitrol treated eyes grew CNS (n=110, p-value=0.0098).

Conclusions: Significant reduction in endophthalmitis causing organisms were observed in the group treated with both Maxitrol and betadine. In patients receiving intravitreal injections, preparing the injection site with a combination of betadine and Maxitrol may reduce the incidence of inadvertent infectious complications.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×